Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) FCF Margin (2016 - 2025)

Historic FCF Margin for Lisata Therapeutics (LSTA) over the last 11 years, with Q2 2025 value amounting to 5651.43%.

  • Lisata Therapeutics' FCF Margin changed N/A to 5651.43% in Q2 2025 from the same period last year, while for Sep 2025 it was 1612.71%, marking a year-over-year change of. This contributed to the annual value of 1935.6% for FY2024, which is N/A changed from last year.
  • Lisata Therapeutics' FCF Margin amounted to 5651.43% in Q2 2025.
  • In the past 5 years, Lisata Therapeutics' FCF Margin ranged from a high of 452.8% in Q4 2024 and a low of 5651.43% during Q2 2025